FDA fast tracks new coronavirus treatments and tests

03:28

Dr. Nahid Bhadelia, an infectious disease physician at Boston University School of Medicine, joins Andrea Mitchell to provide her expertise on what the FDA's moves mean for the coronavirus response, as well as potential risk factors to the drugs being approved for use by covid patients.